Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Shell managed to overturn a Dutch legal order made in 2021 that had mandated the company cut its emissions 45% from 2019 levels by 2030.
Nestlé and Formula 1 announced on Monday that starting with the upcoming 2025 season KitKat will be the sport’s “official chocolate bar.”
Dissapointing results for two mid-stage trials strikes a blow in Abbvie’s expensive pipeline-via-M&A strategy.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Nintendo revealed on Tuesday that it had suffered a 69% drop in its profits year-over-year for the most recent financial quarter.
Ferrari reported improved sales and earnings in the third quarter, extending its streak of outperforming other luxury auto companies.
A recapitalization plan would end News Corp’s dual-class share structure, which gives the Murdoch family outsized control of the company.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Autonomy has been a part of Tesla’s vision for a long time, with its recent focus on robotaxis doubling down on the market.
This weekend, TGI Fridays filed for Chapter 11 bankruptcy, making it the latest in its class to raise the white flag.
Last week the Big Oil companies weighed in with their earnings reports, and it was mostly a pretty sorry assembly.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.